Business Wire | Nov 2, 2021 04:06PM EDT

Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference

Nov. 02, 2021

ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 02, 2021--Cardiovascular Systems, Inc. (CSI(r)) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the Stifel 2021 Virtual Healthcare Conference.

Stifel 2021 Virtual Heathcare Conference Tuesday, November 16, 2021 10:00 a.m. ET Webcast

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005969/en/

CONTACT: Cardiovascular Systems, Inc. Jack Nielsen (651) 202-4919 j.nielsen@csi360.com